Kennedy Capital Management, Inc. Heron Therapeutics, Inc. Transaction History

Kennedy Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $959,932 - $2.3 Million	-93,835 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $45,849 - $70,037	-2,632 Reduced 2.73%	93,835 $2.21 Million
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $44,679 - $58,416	-2,731 Reduced 2.75%	96,467 $1.79 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $1.7 Million - $2.64 Million	-100,675 Reduced 50.37%	99,198 $1.84 Million
Q1 2019 May 13, 2019	BUY	$23.15 - $28.34 $575,809 - $704,900	24,873 Added 14.21%	199,873 $4.89 Million
Q4 2018 Feb 12, 2019	BUY	$22.03 - $32.01 $3.86 Million - $5.6 Million	175,000 New	175,000 $4.54 Million

176

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $210M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.